ENTRY       D07132                      Drug
NAME        Buprenorphine (JAN/INN);
            Temgesic (TN)
PRODUCT     BRIXADI (Braeburn)
            BUTRANS (Purdue Pharma LP)
            SUBLOCADE (Indivior)
  GENERIC   BUPRENORPHENE (Apotex Corp.)
            BUPRENORPHINE (Amneal Pharmaceuticals NY LLC)
            BUPRENORPHINE (Rhodes Pharmaceuticals L.P.)
            BUPRENORPHINE (Teva Pharmaceuticals USA)
            BUPRENORPHINE TRANSDERMAL SYSTEM (Alvogen)
FORMULA     C29H41NO4
EXACT_MASS  467.3036
MOL_WEIGHT  467.6401
CLASS       Analgesic
             DG01984  Opioid analgesics
             DG01586  Opioid receptor antagonist
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Same as: C08007
            Therapeutic category: 1149
            ATC code: N02AE01 N07BC01
            Chemical structure group: DG00820
            Product (DG00820): D07132<JP/US> D00836<JP/US>
            Product (mixture): D10250<US>
EFFICACY    Analgesic, Opioid receptor agonist/antagonist
COMMENT     Morphinan derivative, Oripavine derivative
TARGET      OPRK1 [HSA:4986] [KO:K04214]
            OPRM1 [HSA:4988] [KO:K04215]
  PATHWAY   hsa04080(4986+4988)  Neuroactive ligand-receptor interaction
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07039  Opioid analgesics
            map07224  Opioid receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N02 ANALGESICS
               N02A OPIOIDS
                N02AE Oripavine derivatives
                 N02AE01 Buprenorphine
                  D07132  Buprenorphine (JAN/INN) &lt;JP/US&gt;
              N07 OTHER NERVOUS SYSTEM DRUGS
               N07B DRUGS USED IN ADDICTIVE DISORDERS
                N07BC Drugs used in opioid dependence
                 N07BC01 Buprenorphine
                  D07132  Buprenorphine (JAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Analgesics
              Opioid Analgesics, Long-acting
               Buprenorphine
                D07132  Buprenorphine (JAN/INN)
             Anti-Addiction/Substance Abuse Treatment Agents
              Opioid Dependence
               Buprenorphine
                D07132  Buprenorphine (JAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               114  Antipyretics and analgesics, anti-inflammatory agents
                1149  Others
                 D07132  Buprenorphine (JAN/INN)
            Drug groups [BR:br08330]
             Analgesic
              DG01984  Opioid analgesics
               DG00820  Buprenorphine
                D07132  Buprenorphine
              DG01586  Opioid receptor antagonist
               DG00820  Buprenorphine
                D07132  Buprenorphine
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00820  Buprenorphine
                 D07132  Buprenorphine
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Opioid
                OPRM1
                 D07132  Buprenorphine (JAN/INN) &lt;JP/US&gt;
                OPRK1
                 D07132  Buprenorphine (JAN/INN) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D07132
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D07132
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D07132
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D07132
            Narcotics and psychotropics in Japan [br08308.html]
             Psychotropics by Cabinet order Article 3 (78 substances)
              D07132
            Drug groups [BR:br08330]
             Analgesic
              DG01984  Opioid analgesics
               DG00820  Buprenorphine
              DG01586  Opioid receptor antagonist
               DG00820  Buprenorphine
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00820  Buprenorphine
DBLINKS     CAS: 52485-79-7
            PubChem: 51091471
            ChEBI: 3216
            LigandBox: D07132
            NIKKAJI: J291.229E
ATOM        34
            1   C1z C    16.5998  -15.1247
            2   C1z C    17.7863  -15.8227
            3   C1y C    15.4132  -15.8227
            4   C8y C    16.5998  -13.7986
            5   C1x C    17.7863  -14.4267
            6   C1y C    18.9729  -15.1247
            7   C1x C    17.7863  -17.2186
            8   C1x C    17.2280  -16.8697
            9   C1z C    15.4132  -17.1488
            10  O2x O    14.7851  -14.2872
            11  C8y C    15.4830  -13.1006
            12  C8y C    17.8561  -13.1006
            13  C1x C    20.1595  -14.4267
            14  N1y N    20.1595  -15.8227
            15  C1x C    18.9727  -13.7986
            16  C1y C    16.5998  -17.8468
            17  C1x C    16.0414  -16.1717
            18  C8y C    15.4830  -11.7047
            19  C8x C    17.8561  -11.7047
            20  C1b C    21.3460  -15.1945
            21  C8x C    16.6696  -11.0067
            22  O1a O    14.2965  -11.0067
            23  C1y C    22.5326  -15.8925
            24  C1x C    23.2305  -17.0790
            25  C1x C    23.9285  -15.8925
            26  O2a O    14.0173  -17.1488
            27  C1a C    13.3193  -15.9400
            28  C1d C    17.2978  -19.0557
            29  C1a C    18.6935  -19.0557
            30  C1d C    16.6094  -20.2477
            31  O1a O    17.9861  -20.2478
            32  C1a C    15.2041  -20.2478
            33  C1a C    17.2930  -21.4316
            34  C1a C    15.7619  -21.4443
BOND        40
            1     1   5 1 #Up
            2     2   6 1
            3     2   7 1
            4     2   8 1 #Down
            5     3   9 1
            6     3  10 1 #Down
            7     4  11 1
            8     4  12 2
            9     5  13 1
            10    6  14 1 #Up
            11    6  15 1
            12    7  16 1
            13    8  17 1
            14   11  18 2
            15   12  19 1
            16   14  20 1
            17   18  21 1
            18   18  22 1
            19    9  16 1
            20    9  17 1 #Down
            21   10  11 1
            22   12  15 1
            23   14  13 1 #Up
            24   19  21 2
            25    1   2 1
            26   20  23 1
            27    1   3 1
            28    1   4 1
            29   23  24 1
            30   23  25 1
            31   25  24 1
            32    9  26 1
            33   26  27 1
            34   16  28 1
            35   28  29 1 #Up
            36   28  30 1
            37   28  31 1 #Down
            38   30  32 1
            39   30  33 1
            40   30  34 1
///
